Response rates and pathologic complete response by breast cancer molecular subtype following neoadjuvant chemotherapy

Response to Neoadjuvant Therapy and Long-Term Survival in Patients With Triple-Negative Breast Cancer

Cornelia Liedtke, Chafika Mazouni, Kenneth R. Hess et al. · Journal of Clinical Oncology · 2008 · 2.9K citations · Full text

Medicine, Oncology, Breast Oncology +16

The Triple Negative Paradox: Primary Tumor Chemosensitivity of Breast Cancer Subtypes

Lisa A. Carey, Elizabeth Claire Dees, Lynda Sawyer et al. · Clinical Cancer Research · 2007 · 2.1K citations · Full text

Medicine, Oncology, Breast Oncology +14

The National Cancer Data Base: A Powerful Initiative to Improve Cancer Care in the United States

Karl Y. Bilimoria, Andrew K. Stewart, David P. Winchester et al. · Annals of Surgical Oncology · 2008 · 1.8K citations · Full text

Medicine, Health Care Management, Oncology +16

Residual Ductal Carcinoma In Situ in Patients With Complete Eradication of Invasive Breast Cancer After Neoadjuvant Chemotherapy Does Not Adversely Affect Patient Outcome

Chafika Mazouni, Florentia Peintinger, Shu Wan-Kau et al. · Journal of Clinical Oncology · 2007 · 308 citations · Full text

Medicine, Oncology, Surgery +17

St. Gallen 2013: Brief Preliminary Summary of the Consensus Discussion

Nadia Harbeck, Christoph Thomssen, Michael Gnant · Breast Care · 2013 · 172 citations · Full text

Medicine, Endocrinology, Oncology +11